Choosing the Right Dimension of Purity
Croda
The UK MHRA wants Pharmas to share their thoughts on the regulations governing the industry – including those on manufacturing and safety – under the UK Government’s ‘Red Tape Challenge.’
The idea – according to the official website – is to get the industry’s take on the rules that govern all aspects of drug licensing, manufacturing, sale, distribution, advertising, quality and efficacy to identify areas where the regulatory burden can be reduced.
MHRA press officer Nick Spears told in-Pharmatechnologist.com that: “We want to encourage ideas and stimulate discussions from business, patients and the public and all those affected by our regulations to help improve medicines regulation, without compromising safety.”
“We welcome all suggestions and they will all be considered to identify areas for change and more effective ways of achieving common goals to improve how we currently regulate medicines.”
Feedback submitted over the next five weeks will be reviewed by the MHRA before being put before a Government committee, which will publish its conclusions sometime in the next three months.
The focus will be on removing legislation according to the MHRA who said that: “[The committee will] meticulously go through the regulations with the presumption that they will go unless they can be strongly justified.”
